Identification of a lncRNA/circRNA-miRNA-mRNA network in Nasopharyngeal Carcinoma by deep sequencing and bioinformatics analysis
- PMID: 38434987
- PMCID: PMC10905391
- DOI: 10.7150/jca.91546
Identification of a lncRNA/circRNA-miRNA-mRNA network in Nasopharyngeal Carcinoma by deep sequencing and bioinformatics analysis
Abstract
Background: Accumulating evidence indicates that non-coding RNAs (ncRNA), including long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs), can function as competitive endogenous RNAs (ceRNAs) by binding to microRNAs (miRNAs) and regulating host gene expression at the transcriptional or post-transcriptional level. Dysregulation in ceRNA network regulation has been implicated in the occurrence and development of cancer. However, the lncRNA/circRNA-miRNA-mRNA regulatory network is still lacking in nasopharyngeal carcinoma (NPC). Methods: Differentially expressed genes (DEGs) were obtained from our previous sequencing data and Gene Expression Omnibus (GEO). Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes pathway (KEGG) were used to explore the biological functions of these common DEGs. Through a series of bioinformatic analyses, the lncRNA/circRNA-miRNA-mRNA network was established. In additional, the external data GSE102349 was used to test the prognostic value of the hub mRNAs through the Kaplan-Meier method. Results: We successfully constructed a lncRNA/circRNA-miRNA-mRNA network in NPC, consisting of 16 lncRNAs, 6 miRNAs, 3 circRNAs and 10 mRNAs and found that three genes (TOP2A, ZWINT, TTK) were significantly associated with overall survival time (OS) in patients. Conclusion: The regulatory network revealed in this study may help comprehensively elucidate the ceRNA mechanisms driving NPC, and provide novel candidate biomarkers for evaluating the prognosis of NPC.
Keywords: bioinformatics; competitive endogenous RNA; deep sequencing; nasopharyngeal carcinoma; non-coding RNAs.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures







Similar articles
-
Identification of a lncRNA/circRNA-miRNA-mRNA ceRNA Network in Alzheimer's Disease.J Integr Neurosci. 2023 Oct 17;22(6):136. doi: 10.31083/j.jin2206136. J Integr Neurosci. 2023. PMID: 38176923
-
Identification of Serum Exosome-Derived circRNA-miRNA-TF-mRNA Regulatory Network in Postmenopausal Osteoporosis Using Bioinformatics Analysis and Validation in Peripheral Blood-Derived Mononuclear Cells.Front Endocrinol (Lausanne). 2022 Jun 9;13:899503. doi: 10.3389/fendo.2022.899503. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35757392 Free PMC article.
-
Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.Bioengineered. 2021 Dec;12(2):12821-12838. doi: 10.1080/21655979.2021.2003925. Bioengineered. 2021. PMID: 34898376 Free PMC article.
-
Insight into LncRNA- and CircRNA-Mediated CeRNAs: Regulatory Network and Implications in Nasopharyngeal Carcinoma-A Narrative Literature Review.Cancers (Basel). 2022 Sep 20;14(19):4564. doi: 10.3390/cancers14194564. Cancers (Basel). 2022. PMID: 36230487 Free PMC article. Review.
-
Recent progress of exosomal lncRNA/circRNA-miRNA-mRNA axis in lung cancer: implication for clinical application.Front Mol Biosci. 2024 Jul 3;11:1417306. doi: 10.3389/fmolb.2024.1417306. eCollection 2024. Front Mol Biosci. 2024. PMID: 39021878 Free PMC article. Review.
Cited by
-
The interplay of p16INK4a and non-coding RNAs: bridging cellular senescence, aging, and cancer.Biogerontology. 2025 Feb 5;26(2):50. doi: 10.1007/s10522-025-10194-2. Biogerontology. 2025. PMID: 39907830 Review.
-
Bioinformatics and immunoinformatics approaches in the design of a multi-epitope vaccine targeting CTLA-4 for melanoma treatment.Mol Divers. 2025 Jan 28. doi: 10.1007/s11030-025-11108-7. Online ahead of print. Mol Divers. 2025. PMID: 39873886
-
Current Research in Drug-Free Cancer Therapies.Bioengineering (Basel). 2025 Mar 26;12(4):341. doi: 10.3390/bioengineering12040341. Bioengineering (Basel). 2025. PMID: 40281701 Free PMC article. Review.
-
Non-coding RNAs as key players in neurodegeneration and brain tumors: Insights into therapeutic strategies.Iran J Basic Med Sci. 2025;28(8):962-985. doi: 10.22038/ijbms.2025.85350.18446. Iran J Basic Med Sci. 2025. PMID: 40584439 Free PMC article. Review.
-
Microbiota and Cytokine Modulation: Innovations in Enhancing Anticancer Immunity and Personalized Cancer Therapies.Biomedicines. 2024 Dec 6;12(12):2776. doi: 10.3390/biomedicines12122776. Biomedicines. 2024. PMID: 39767682 Free PMC article. Review.
References
-
- Chang ET, Adami H-O. The Enigmatic Epidemiology of Nasopharyngeal Carcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15:1765–77. - PubMed
-
- Chen Y-P, Chan ATC, Le Q-T, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. The Lancet. 2019;394:64–80. - PubMed
-
- Yuan L, EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma. Cell Death Differ [Internet]. 2022 [cited. 2023. Feb 12];29. Available from: https://pubmed.ncbi.nlm.nih.gov/35105963/ - PMC - PubMed
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous